Maria G. Olivares

Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins

Marta Guix, Anthony C. Faber, Shizhen Emily Wang et al. · Journal of Clinical Investigation · 2008 · 522 citations · Full text

Tumor Biology, Signal Transduction, Health Sciences +15

Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase

Joan T. Garrett, Maria G. Olivares, Cammie Rinehart et al. · Proceedings of the National Academy of Sciences · 2011 · 455 citations · Full text

Pi3k Pathway, Tumor Biology, Transcriptional Regulation +20

Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation

Joshua A. Bauer, A. Bapsi Chakravarthy, Jennifer M. Rosenbluth et al. · Clinical Cancer Research · 2010 · 186 citations · Full text

Transforming Growth Factor β Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab

Shizhen Emily Wang, Bin Xiang, Marta Guix et al. · Molecular and Cellular Biology · 2008 · 168 citations · Full text

Signal Transduction, Signaling Pathway, Gene Signature +15

Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells

Todd W. Miller, James T. Forbes, Chirayu Shah et al. · Clinical Cancer Research · 2009 · 131 citations · Full text